ArticleThe Journal of clinical investigation2026

CD73 inhibition overcomes adaptive immune resistance to PARP inhibition in models of prostate cancer.

Ping Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.